AZN — AstraZeneca Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
£198.21bn
Enterprise Value
£217.54bn
Revenue
$54.07bn

REG - Competition and Mkts - Merger Update: AstraZeneca/Alexion
25/05/2021 08:05Announcement
REG - AstraZeneca PLC - EMTN programme update - publication of Prospectus
25/05/2021 07:05Announcement
REG - AstraZeneca PLC - Vaxzevria COVID-19 vaccine approved in Japan
21/05/2021 07:05Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding
18/05/2021 15:30Announcement
REG - AstraZeneca PLC - Result of AGM
11/05/2021 14:05Announcement
REG - AstraZeneca PLC - Shareholders vote in favour of Alexion acquisition
11/05/2021 14:00Announcement
REG - AstraZeneca PLC - Imfinzi + tremelimumab showed survival in POSEIDON
07/05/2021 07:00Announcement
REG - Circassia Group Plc AstraZeneca PLC - Holding(s) in Company
05/05/2021 18:35Announcement
REG - AstraZeneca PLC - Total Voting Rights
04/05/2021 15:05Announcement
REG - AstraZeneca PLC - Farxiga approved in the US for CKD
04/05/2021 07:06Announcement
REG - AstraZeneca PLC - AZN: First quarter 2021 results
30/04/2021 07:00Announcement
REG - AstraZeneca PLC - Selumetinib recommended for EU approval in NF1
26/04/2021 07:15Announcement
REG - AstraZeneca PLC - Tagrisso adjuvant receives positive CHMP opinion
26/04/2021 07:10Announcement
REG - AstraZeneca PLC - Nirsevimab Phase III trial met primary endpoint
26/04/2021 07:00Announcement
REG - AstraZeneca PLC - US clearance of proposed acquisition of Alexion
16/04/2021 12:05Announcement
REG - AstraZeneca PLC - Tagrisso approved in China in early lung cancer
14/04/2021 07:05Announcement
REG - AstraZeneca PLC - Circular and notice of general meeting
12/04/2021 13:00Announcement
REG - AstraZeneca PLC - Update on Farxiga COVID-19 DARE-19 Phase III trial
12/04/2021 07:05Announcement
REG - AstraZeneca PLC - Total Voting Rights
01/04/2021 15:00Announcement
REG - AstraZeneca PLC - Notice of AGM
30/03/2021 12:15Announcement